Temazepam and Pamelor drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Temazepam (temazepam) and Pamelor (nortriptyline hydrochloride). Common drug interactions include pain among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people have when they take Temazepam and Pamelor. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.

What is Temazepam?

Temazepam has active ingredients of temazepam. It is often used in insomnia. eHealthMe is studying from 42,106 Temazepam users. Check the latest studies of Temazepam.

What is Pamelor?

Pamelor has active ingredients of nortriptyline hydrochloride. It is often used in migraine. eHealthMe is studying from 4,069 Pamelor users. Check the latest studies of Pamelor.



On Jul, 10, 2026

27 people who take Temazepam and Pamelor together, and have interactions are studied.

Temazepam and Pamelor drug interactions.

What are the common drug interactions of Temazepam and Pamelor, by gender? *:

female:

  1. Pain
  2. Anxiety
  3. Fluid retention (an abnormal accumulation of fluid in the blood)
  4. Glaucoma (increased fluid pressure in the eye with vision loss)
  5. Hypertension (high blood pressure)
  6. Obsessive-compulsive disorder (an anxiety disorder characterized by intrusive thoughts that produce uneasiness, apprehension, fear, or worry;)
  7. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  8. Suicidal ideation
  9. Carpal tunnel decompression
  10. Cataplexy (loss of muscle tone accompanied by full conscious awareness)

male:

  1. Drug ineffective
  2. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
  3. Drug tolerance increased
  4. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  5. Fatigue (feeling of tiredness)
  6. Gait disturbance
  7. Herpes zoster
  8. Hyperhidrosis (abnormally increased sweating)
  9. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  10. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)

What are the common drug interactions of Temazepam and Pamelor, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Drug ineffective
  2. Erythema (redness of the skin)
  3. Face oedema (swelling of face)
  4. Fall
  5. Pruritus (severe itching of the skin)
  6. Therapeutic response unexpected

20-29:

n/a

30-39:

  1. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)

40-49:

  1. Suicidal ideation
  2. Anger
  3. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
  4. Anxiety
  5. Asthenia (weakness)
  6. Chills (felling of cold)
  7. Completed suicide (act of taking one's own life)
  8. Cyst (a closed sac)
  9. Drug abuser
  10. Drug addiction

50-59:

  1. Brugada syndrome (life-threatening heart rhythm disorder)
  2. Cataract (clouding of the lens inside the eye)
  3. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  4. Pulmonary fibrosis (formation or development of excess fibrous connective tissue (fibrosis) in the lungs)
  5. Weight decreased

60+:

  1. Arthralgia (joint pain)
  2. Arthropathy
  3. Stress
  4. Visual impairment
  5. Drug ineffective
  6. Foot deformity (functional disability of foot)
  7. Gait disturbance
  8. Memory impairment
  9. Mobility decreased (ability to move is reduced)
  10. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 9 people, 33.33%
  2. Bone Disorder: 4 people, 14.81%
  3. Pain: 2 people, 7.41%
  4. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 7.41%
  5. High Blood Pressure: 2 people, 7.41%
  6. Fibromyalgia (a long-term condition which causes pain all over the body): 2 people, 7.41%
  7. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 7.41%

* Approximation only. Some reports may have incomplete information.

Do you take Temazepam and Pamelor?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Temazepam and Pamelor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Temazepam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Pamelor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Temazepam and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pamelor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on temazepam and nortriptyline hydrochloride (the active ingredients of Temazepam and Pamelor, respectively), and Temazepam and Pamelor (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: